Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/200235
Title: | Optimal Timing for Cardiac Surgery in Infective Endocarditis with Neurological Complications: A Narrative Review |
Author: | Siquier Padilla, Joan Cuervo Requena, Guillermo Urra, Xabier Quintana, Eduard Hernández-Meneses, Marta Sandoval, Elena Lapeña, Pau Falces Salvador, Carles Mestres, Carlos A. Paez Carpio, Alfredo Moreno Camacho, Ma. Asunción Miró Meda, José M. Hospital Clinic Endocarditis Team Investigators |
Keywords: | Infart cerebral Endocarditis Hemorràgia Malalts cardíacs Meningitis Micotoxines Aneurismes aòrtics Cirurgia cardíaca Complicacions quirúrgiques Cerebral infarctio Endocarditis Hemorrhage Cardiac patients Meningitis Mycotoxins Aortic aneurysms Heart surgery Complications of surgery |
Issue Date: | 7-Sep-2022 |
Publisher: | MDPI |
Abstract: | In patients with infective endocarditis and neurological complications, the optimal timing for cardiac surgery is unclear due to the varied risk of clinical deterioration when early surgery is performed. The aim of this review is to summarize the best evidence on the optimal timing for cardiac surgery in the presence of each type of neurological complication. An English literature search was carried out from June 2018 through July 2022. The resulting selection, comprising observational studies, clinical trials, systematic reviews and society guidelines, was organized into four sections according to the four groups of neurological complications: ischemic, hemorrhagic, infectious, and asymptomatic complications. Cardiac surgery could be performed without delay in cases of ischemic vascular neurological complication (provided the absence of severe damage, which can be avoided with the performance of mechanical thrombectomy in cases of major stroke), as well as infectious or asymptomatic complications. In the presence of intracranial hemorrhage, a delay of four weeks is recommended for most cases, although recent studies have suggested that performing cardiac surgery within four weeks could be a suitable option for selected cases. The findings of this review are mostly in line with the recommendations of the current European and American infective endocarditis guidelines. |
Note: | Reproducció del document publicat a: https://doi.org/10.3390/jcm11185275 |
It is part of: | Journal of Clinical Medicine, 2022, vol. 11, num. 18, p. 5275 |
URI: | http://hdl.handle.net/2445/200235 |
Related resource: | https://doi.org/10.3390/jcm11185275 |
ISSN: | 2077-0383 |
Appears in Collections: | Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer) Articles publicats en revistes (Medicina) Articles publicats en revistes (Institut de Neurociències (UBNeuro)) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
729631.pdf | 647.84 kB | Adobe PDF | View/Open |
This item is licensed under a
Creative Commons License